rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Larry R. Miller

General Counsel

Company insider

Files Form 4 as: General Counsel, SIGA Technologies.

In numbers

Trades disclosed
29
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
25 Mar 2024
Last trade
25 Mar 2026
Last filed
26 Mar 2026

Companies traded

Where they are an officer
SIGA SIGA TechnologiesOfficer · Pharmaceuticals · last 25 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
25 Mar 2026filed 26 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing
25 Mar 2026filed 26 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code F$18K3,526 at $4.99filing
25 Mar 2026filed 26 Mar 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing
25 Mar 2026filed 26 Mar 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing
25 Mar 2026filed 26 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing
25 Mar 2026filed 26 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code F$18K3,526 at $4.99filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—21,261 at $0.00filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code F$59K11,187 at $5.26filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—21,261 at $0.00filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—21,261 at $0.00filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—68,060 at $0.00filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—68,060 at $0.00filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—21,261 at $0.00filing
13 Mar 2026filed 17 Mar 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code F$59K11,187 at $5.26filing
18 Apr 2025filed 21 Apr 2025SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing
18 Apr 2025filed 21 Apr 2025SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code D—13,841 at $0.00filing
18 Apr 2025filed 21 Apr 2025SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—13,841 at $0.00filing
18 Apr 2025filed 21 Apr 2025SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing
18 Apr 2025filed 21 Apr 2025SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code F$21K3,532 at $5.99filing
25 Mar 2025filed 26 Mar 2025SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,920 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Holly L. PhillipsDirector · Director at Siga Technologies, filing Form 4 there in the last year
John M. KeaneDirector · Director at Siga Technologies, filing Form 4 there in the last year
Julian NemirovskyDirector · Director at Siga Technologies, filing Form 4 there in the last year
Gary J. NabelDirector · Director at Siga Technologies, filing Form 4 there in the last year
Jaymie A. DurnanDirector · Director at Siga Technologies, filing Form 4 there in the last year